{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T23:19:08Z","timestamp":1784330348051,"version":"3.55.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"17","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s40265-019-01218-6","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T08:03:16Z","timestamp":1573545796000},"page":"1905-1909","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Trifarotene: First Approval"],"prefix":"10.1007","volume":"79","author":[{"given":"Lesley J.","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"issue":"12 Suppl","key":"1218_CR1","first-page":"s51","volume":"17","author":"AL Chien","year":"2018","unstructured":"Chien AL. Retinoids in acne management: review of current understanding, future considerations, and focus on topical treatments. J Drugs Dermatol. 2018;17(12 Suppl):s51\u20135.","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"1218_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s40257-019-00423-z","volume":"20","author":"SS Kolli","year":"2019","unstructured":"Kolli SS, Pecone D, Pona A, et al. Topical retinoids in acne vulgaris: a systematic review. Am J Clin Dermatol. 2019;20(3):345\u201365.","journal-title":"Am J Clin Dermatol"},{"key":"1218_CR3","unstructured":"US National Institue of Health. Lamellar ichthyosis. 2019. http:\/\/ghr.nlm.nih.gov\/condition\/lamellar-ichthyosis#diagnosis. Accessed 15 Oct 2019."},{"issue":"1","key":"1218_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s40257-017-0313-x","volume":"19","author":"A Vahlquist","year":"2018","unstructured":"Vahlquist A, Fischer J, T\u00f6rm\u00e4 H. Inherited nonsyndromic ichthyoses: an update on pathophysiology, diagnosis and treatment. Am J Clin Dermatol. 2018;19(1):51\u201366.","journal-title":"Am J Clin Dermatol"},{"key":"1218_CR5","unstructured":"FDA. Novel drug approvals for 2019. 2019. http:\/\/www.fda.gov. Accessed 15 Oct 2019."},{"key":"1218_CR6","unstructured":"Galderma. Aklief\u00ae (Trifarotene): US Prescribing Information. 2019. http:\/\/www.galderma.com\/. Accessed 2019 Oct 8."},{"key":"1218_CR7","unstructured":"Galderma. Galderma trifarotene development program meets key milestone for lamellar ichthyosis orphan disease [media release]. 2016. http:\/\/www.galderma.com\/. Accessed 15 Oct 2019."},{"issue":"2","key":"1218_CR8","first-page":"442","volume":"179","author":"J Aubert","year":"2018","unstructured":"Aubert J, Piwnica D, Bertino B, et al. Nonclinical and human pharmacology of the potent and selective topical retinoic acid receptor-gamma agonist trifarotene. Br J Dermatol. 2018;179(2):442\u201356.","journal-title":"Br J Dermatol"},{"key":"1218_CR9","unstructured":"Thoreau E, Arlabosse J, Bouix-Peter C, et al. Structure-based design of trifarotene, a potent and selective RAR agonist for the treatment of acne. Bioorg Med Chem Lett. 2018;128(101736-41)."},{"issue":"6","key":"1218_CR10","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/j.jaad.2019.02.044","volume":"80","author":"J Tan","year":"2019","unstructured":"Tan J, Thiboutot D, Popp G, et al. Randomized phase 3 evaluation of trifarotene 50\u00a0\u03bcg\/g cream treatment of moderate facial and truncal acne. J Am Acad Dermatol. 2019;80(6):1691\u20139.","journal-title":"J Am Acad Dermatol"},{"key":"1218_CR11","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15794","author":"U Blume-Peytavi","year":"2019","unstructured":"Blume-Peytavi U, Fowler J, Kem\u00e9ny L, et al. Long-term safety and efficacy of trifarotene 50\u00a0\u03bcg\/g cream, a first-in-class RAR-\u03b3 selective topical retinoid, in patients with moderate facial and truncal acne. J Eur Acad Dermatol Venereol. 2019. https:\/\/doi.org\/10.1111\/jdv.15794.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1218_CR12","unstructured":"Galderma (2019) Data on file"}],"container-title":["Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-019-01218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40265-019-01218-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40265-019-01218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,11]],"date-time":"2020-11-11T00:48:46Z","timestamp":1605055726000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40265-019-01218-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":12,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1218"],"URL":"https:\/\/doi.org\/10.1007\/s40265-019-01218-6","relation":{},"ISSN":["0012-6667","1179-1950"],"issn-type":[{"value":"0012-6667","type":"print"},{"value":"1179-1950","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"12 November 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The preparation of this review was not supported by any external funding.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from any comments received were made by the authors on the basis of scientific completeness and accuracy. Lesley Scott is a salaried employee of Adis International Ltd\/Springer Nature, is responsible for the article content and declares no relevant conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}